loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Awarded - Drug discount agreement for the drugs Advate (B02BD02), Recombinate (B02BD02), Rixubis (B02BD04), Feiba (B02BD03), Immunate (B02BD06), Immuseven (B02BD05), Adynovi (B02BD02), Veyvondi (B02BD10) - 607562

World Biggest Tenders Source

This tender with title Awarded - Drug discount agreement for the drugs Advate (B02BD02), Recombinate (B02BD02), Rixubis (B02BD04), Feiba (B02BD03), Immunate (B02BD06), Immuseven (B02BD05), Adynovi (B02BD02), Veyvondi (B02BD10) - 607562 has been published on Bidding Source portal dated 10 Sep 2026 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Awarded - Drug discount agreement for the drugs Advate (B02BD02), Recombinate (B02BD02), Rixubis (B02BD04), Feiba (B02BD03), Immunate (B02BD06), Immuseven (B02BD05), Adynovi (B02BD02), Veyvondi (B02BD10) - 607562
Contract Award
607562
Germany
10 Sep 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient guanfacine (ATC code: N06BA21). - 603222 Germany Open house drug discount agreements for the active ingredient axitinib, ATC L01EK01 - 602793 Germany Open house drug discount agreements for the active ingredients oxycodone and naloxone, ATC N02AA55 - 605364 Germany Open house drug discount agreements for the active ingredient ticagrelor, ATC B01AC24 - 605329 Germany Open house drug discount agreements for the active ingredient dimethyl fumarate, ATC L04AX07 - 605017 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the aforementioned active ingredients, with the option of concluding such agreements within the framework of the so-called open-house procedure. - 608240 Germany Awarded - Drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in conjunction with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the drug Factor VIII SDH (B02BD02) for the treatment of hemophilia - 606717 Germany Awarded - Drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in conjunction with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the drugs Haemoctin SDH (B02BD02) and Haemonine (B02BD04) for the treatment of hemophilia - 607005 Germany Awarded - Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient emtricitabine + rilpivirine + tenofovir disoproxil fumarate, ATC J05AR08 fd Z. 01.09.24 - 31.08.26 - 607072 Germany Awarded - Drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) in conjunction with Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the drug Fanhdi (B02BD06) for the treatment of hemophilia - 607378 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans